Stem cell therapy for retinal disease

Current Opinion in Ophthalmology

Volumn 23, Issue 3, 2012, Pages 226-234

  Tibbetts, Michael D ^a   Samuel, Michael A ^b   Chang, Tom S ^b   Ho, Allen C ^a  

^a WILLS EYE HOSPITAL   (United States)

^b Retina Institute of California   (United States)

Author keywords

macular degeneration; pluripotent; retina transplant; retinal dystrophy; stem cell

Indexed keywords

CELL DIFFERENTIATION; CELL FATE; CELL REGENERATION; CELL SURVIVAL; CYTOLOGY; EMBRYONIC STEM CELL; HUMAN; MONONUCLEAR CELL; NONHUMAN; PHOTORECEPTOR; PIGMENT CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RETINA CELL; RETINA DISEASE; RETINA DYSTROPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; STARGARDT DISEASE; STEM CELL TRANSPLANTATION; VISION; VISUAL ACUITY;

CLINICAL TRIALS AS TOPIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; RETINAL DISEASES; STEM CELL TRANSPLANTATION;

EID: 84859724908     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328352407d     Document Type: Review

References (62)

1. Baker PS, Brown GC. Stem-cell therapy in retinal disease. Curr Opin Ophthalmol 2009; 20:175-181.
2. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008; 358:2240-2248. (Pubitemid 351724453)
3. Maguire AM, High KA, Auricchio A, et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 2009; 374:1597-1605.
4. Rizzo JF 3rd. Update on retinal prosthetic research: the Boston Retinal Implant Project. J Neuroophthalmol 2011; 31:160-168.
5. Second sight announces first commercial implant of retinal prosthesis. http:// 2-sight.eu/images/stories/2-sight/pdf/20111102-first-commercial-implant- final.pdf. [Accessed 1 January 2011]
6. Bull ND, Martin KR. Concise review: toward stem cell-based therapies for retinal neurodegenerative diseases. Stem Cells 2011; 29:1170-1175.
7. Ashtari M, Cyckowski LL, Monroe JF, et al. The human visual cortex responds to gene therapy-mediated recovery of retinal function. J Clin Invest 2011; 121:2160-2168.
8. Banin E, Obolensky A, Idelson M, et al. Retinal incorporation and differentiation of neural precursors derived from human embryonic stem cells. Stem Cells 2006; 24:246-257. (Pubitemid 44464792)
9. Lund RD, Wang S, Klimanskaya I, et al. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 2006; 8:189-199. (Pubitemid 44735173)
10. Klimanskaya I, Hipp J, Rezai KA, et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004; 6:217-245. (Pubitemid 39391307)
11. Lu B, Malcuit C, Wang S, et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009; 27:2126-2135. This study demonstrated that RPE can be derived from human ESCs using Good Manufacturing Practices, which allowed for these cells to be used in human clinical trials.
12. Idelson M, Alper R, Obolensky A, et al. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009; 5:396-408.
13. Osakada F, Ikeda H, Sasai Y, Takahashi M. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc 2009; 4:811-824.
14. Osakada F, Ikeda H, Mandai M, et al. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 2008; 26:215-224. (Pubitemid 351225958)
15. Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci U S A 2006; 103:12769-12774. (Pubitemid 44298636)
16. Lamba DA, Gust J, Reh TA. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell 2009; 4:73-79.
17. Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration. Science 2008; 322:945-949.
18. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676. (Pubitemid 44233629)
19. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448:318-324. (Pubitemid 47080337)
20. Woltjen K, Michael IP, Mohseni P, et al. PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458:766-770.
21. Okita K, Nakagawa M, Hyenjong H, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322:949-953.
22. Parameswaran S, Balasubramanian S, Babai N, et al. Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration. Stem Cells 2010; 28:695-703.
23. Wilmut I, Beaujean N, de Sousa PA, et al. Somatic cell nuclear transfer. Nature 2002; 419:583-586.
24. Osakada F, Jin ZB, Hirami Y, et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 2009; 122 (Pt 17):3169-3179.
25. Hirami Y, Osakada F, Takahashi K, et al. Generation of retinal cells from mouse and human induced pluripotent stemcells. Neurosci Lett 2009; 458:126-131.
26. Lamba DA, McUsic A, Hirata RK, et al. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS One 2010; 5:e8763.
27. Meyer JS, Shearer RL, Capowski EE, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A 2009; 106:16698-16703.
28. Carr AJ, Vugler AA, Hikita ST, et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 2009; 4:e8152.
29. Kokkinaki M, Sahibzada N, Golestaneh N. Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 2011; 29:825-835.
30. Boucherie C, Sowden JC, Ali RR. Induced pluripotent stemcell technology for generating photoreceptors. Regen Med 2011; 6:469-479.
31. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321:1218-1221.
32. Meyer JS, Howden SE, Wallace KA, et al.Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 2011; 29:1206-1218. This article demonstrates that human iPSCs derived from a patient with gyrate atrophy can be differentiated into retinal progenitor cells and the disease-specific genetic defect can be functionally repaired by pharmacological means or targeted gene repair.
33. Ali RR, Sowden JC. Regenerative medicine: DIY eye. Nature 2011; 472:42-43.
34. Eiraku M, Takata N, Ishibashi H, et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 2011; 472:51-56. This article demonstrates that a three-dimensional optic cup containing neural retina can be grown in culture from mouse ESCs.
35. Radtke ND, Aramant RB, Seiler MJ, et al. Vision change after sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa. Arch Ophthalmol 2004; 122:1159-1165. (Pubitemid 39031131)
36. Radtke ND, Aramant RB, Petry HM, et al. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol 2008; 146:172-182.
37. Safety and tolerability of sub-retinal transplantation of human embryonic stem cell derived retinal pigmented epithelial (hESC-RPE) cells in patients with Stargardt's Macular Dystrophy (SMD). http://clinicaltrials.gov/ct2/show/ NCT01469832. [Accessed 9 November 2011]
38. Safety and tolerability of sub-retinal transplantation of hESC derived RPE (MA09-hRPE) cells in patients with advanced Dry Age Related Macular Degeneration (Dry AMD). http://clinicaltrials.gov/ct2/show/NCT01344993. [Accessed 20 November 2011]
39. A study of the safety and efficacy of CNTO2476 in patients with age-related macular degeneration. http://clinicaltrials.gov/ct2/show/ NCT01226628. [Accessed 17 November 2011]
40. Autologous bone marrow-derived stem cells transplantation for retinitis pigmentosa. : http://clinicaltrials.gov/ct2/show/NCT01068561. [Accessed 17 November 2011]
41. Schwartz SD, Hubschman JP, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012. [Epub ahead of print] This is the first published description of human ESC-derived cells transplanted into patients. Subretinal transplantation of hESC-derived RPE cells into one patient with Stargardt's macular dystrophy and one patient with dry age-related macular degeneration demonstrated preliminary safety and possible visual acuity benefits.
42. Siqueira RC, Messias A, Voltarelli JC, et al. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina 2011; 31:1207-1214. This paper is the first published article of injecting autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophies. Four of five patients had one line of improvement in visual acuity with no adverse events, but no changes in macular thickness, ERG response or retinal perfusion were observed.
43. Wang NK, Tosi J, Kasanuki JM, et al. Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa. Transplantation 2010; 89:911-919.
44. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 1994; 232:707-716.
45. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci 2004; 45:4151-4160. (Pubitemid 39411174)
46. Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol 2002; 133:215-225. (Pubitemid 34072050)
47. MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology 2005; 112:2081-2087. (Pubitemid 41720984)
48. Drukker M, Katchman H, Katz G, et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006; 24:221-229. (Pubitemid 44464789)
49. Atala A. Human embryonic stem cells: early hints on safety and efficacy. Lancet 2012. [Epub ahead of print]
50. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147. (Pubitemid 28516247)
51. Frantz S. Embryonic stem cell pioneer Geron exits field, cuts losses. Nat Biotechnol 2012; 30:12-13.
52. Cayouette M, Behn D, Sendtner M, et al. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J Neurosci 1998; 18:9282-9293. (Pubitemid 28512459)
53. Faktorovich EG, Steinberg RH, Yasumura D, et al. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990; 347:83-86.
54. Tao W, Wen R, Goddard MB, et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2002; 43:3292-3298.
55. Zhang K, Hopkins JJ, Heier JS, et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci U S A 2011;108:6241-6245. This clinical trial did not utilize stem cell-based therapies, but does demonstrate the potential of trophic cell based therapies for retinal disease.
56. Otani A, Dorrell MI, Kinder K, et al. Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J Clin Invest 2004; 114:765-774. (Pubitemid 39578735)
57. Jonas JB, Witzens-Harig M, Arseniev L, Ho AD. Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report. Acta Ophthalmol 2008; 86:225-226.
58. Lund RD, Wang S, Lu B, et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007; 25:602-611. (Pubitemid 46354218)
59. Lakowski J, Han YT, Pearson RA, et al. Effective transplantation of photoreceptor precursor cells selected via cell surface antigen expression. Stem Cells 2011; 29:1391-1404.
60. MacLaren RE, Pearson RA, MacNeil A, et al. Retinal repair by transplantation of photoreceptor precursors. Nature 2006; 444:203-207. (Pubitemid 44722060)
61. Yang Y, Mohand-Said S, Leveillard T, et al. Transplantation of photoreceptor and total neural retina preserves cone function in P23H rhodopsin transgenic rat. PLoS One 2010; 5:e13469.
62. West EL, Pearson RA, Barker SE, et al. Long-term survival of photoreceptors transplanted into the adult murine neural retina requires immune modulation. Stem Cells 2010; 28:1997-2007.